Your browser doesn't support javascript.
loading
Arrhythmogenic cardiomyopathy and differential diagnosis with physiological right ventricular remodelling in athletes using cardiovascular magnetic resonance.
Moccia, Eleonora; Papatheodorou, Efstathios; Miles, Chris J; Merghani, Ahmed; Malhotra, Aneil; Dhutia, Harshil; Bastiaenen, Rachel; Sheikh, Nabeel; Zaidi, Abbas; Sanna, Giuseppe Damiano; Homfray, Tessa; Bunce, Nicholas; Anderson, Lisa J; Tome, Maite; Behr, Elijah; Moon, James; Sharma, Sanjay; Finocchiaro, Gherardo; Papadakis, Michael.
Afiliação
  • Moccia E; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospital NHS Foundation Trust, London, UK. e.moccia@studenti.uniss.it.
  • Papatheodorou E; Clinical and Interventional Cardiology, Sassari University Hospital, Via Enrico de Nicola 1, Sassari, Italy. e.moccia@studenti.uniss.it.
  • Miles CJ; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospital NHS Foundation Trust, London, UK.
  • Merghani A; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospital NHS Foundation Trust, London, UK.
  • Malhotra A; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospital NHS Foundation Trust, London, UK.
  • Dhutia H; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospital NHS Foundation Trust, London, UK.
  • Bastiaenen R; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospital NHS Foundation Trust, London, UK.
  • Sheikh N; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospital NHS Foundation Trust, London, UK.
  • Zaidi A; Guy's and St, Thomas's Hospital, London, UK.
  • Sanna GD; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospital NHS Foundation Trust, London, UK.
  • Homfray T; Guy's and St, Thomas's Hospital, London, UK.
  • Bunce N; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospital NHS Foundation Trust, London, UK.
  • Anderson LJ; University Hospital of Wales, Cardiology, Cardiff, UK.
  • Tome M; Clinical and Interventional Cardiology, Sassari University Hospital, Via Enrico de Nicola 1, Sassari, Italy.
  • Behr E; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospital NHS Foundation Trust, London, UK.
  • Moon J; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospital NHS Foundation Trust, London, UK.
  • Sharma S; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospital NHS Foundation Trust, London, UK.
  • Finocchiaro G; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospital NHS Foundation Trust, London, UK.
  • Papadakis M; Cardiology Clinical Academic Group, St George's University of London and St George's University Hospital NHS Foundation Trust, London, UK.
Int J Cardiovasc Imaging ; 38(12): 2723-2732, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36445664
ABSTRACT
To describe the overlap between structural abnormalities typical of arrhythmogenic right ventricular cardiomyopathy (ARVC) and physiological right ventricular adaptation to exercise and differentiate between pathologic and physiologic findings using CMR. We compared CMR studies of 43 patients (mean age 49 ± 17 years, 49% males, 32 genotyped) with a definitive diagnosis of ARVC with 97 (mean age 45 ± 16 years, 61% males) healthy athletes. CMR was abnormal in 37 (86%) patients with ARVC, but only 23 (53%) fulfilled a major or minor CMR criterion according to the TFC. 7/20 patients who did not fulfil any CMR TFC showed pathological finding (RV RWMA and fibrosis in the LV or LV RWMA). RV was affected in isolation in 17 (39%) patients and 18 (42%) patients showed biventricular involvement. Common RV abnormalities included RWMA (n = 34; 79%), RV dilatation (n = 18; 42%), RV systolic dysfunction (≤ 45%) (n = 17; 40%) and RV LGE (n = 13; 30%). The predominant LV abnormality was LGE (n = 20; 47%). 22/32 (69%) patients exhibited a pathogenic variant PKP2 (n = 17, 53%), DSP (n = 4, 13%) and DSC2 (n = 1, 3%). Sixteen (16%) athletes exceeded TFC cut-off values for RV volumes. None of the athletes exceeded a RV/LV end-diastolic volume ratio > 1.2, nor fulfilled TFC for impaired RV ejection fraction. The majority (86%) of ARVC patients demonstrate CMR abnormalities suggestive of cardiomyopathy but only 53% fulfil at least one of the CMR TFC. LV involvement is found in 50% cases. In athletes, an RV/LV end-diastolic volume ratio > 1.2 and impaired RV function (RVEF ≤ 45%) are strong predictors of pathology.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Displasia Arritmogênica Ventricular Direita / Remodelação Ventricular Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Displasia Arritmogênica Ventricular Direita / Remodelação Ventricular Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article